Abano Healthcare Group Limited provided earnings guidance for the year ended May 31, 2013. Following the divestment of its brain injury rehabilitation business, Abano Rehabilitation, in June 2012, Abano Healthcare Group expects reported consolidated revenues to grow to between $207.0 million to $209.0 million, with earnings before interest, tax, depreciation and amortisation (EBITDA) of between $27.5 million to $28.5 million and a net profit after tax (NPAT) of between $2.3 million to $2.8 million. Underlying EBITDA is expected to be between $28.3 million to $29.3 million, resulting in an underlying NPAT of between $4.1 million to $4.6 million.